Skip to content

Policy in focus: Is psilocybin the next cannabis?

Greg Basky

Canadian Medical Association Journal November 14, 2021 DOI: 10.1503/cmaj.1095974 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Review Peer reviewed
Intervention Psilocybin
Topics Addiction Cannabis Psilocybin
Keywords Magic telescope Hallucinogen Focus optics
Citations 7
Key findings Research into the therapeutic use of psilocybin for depression and addiction is growing alongside unregulated dispensaries.

Abstract

Research interest in the therapeutic use of psilocybin, or "magic mushrooms," is growing alongside a "wild west" of dispensaries in Canada and the United States. The past decade has seen a revival of research exploring the clinical use of psychedelics in treating depression, addiction,

Explore topics